Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Dynavax Technologies Q2 EPS $0.14 Beats $0.09 Estimate, Sales $91.872M Beat $85.914M Estimate

Author: Benzinga Newsdesk | August 07, 2025 03:02pm
Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 60.92 percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $91.872 million which beat the analyst consensus estimate of $85.914 million by 6.93 percent. This is a 24.50 percent increase over sales of $73.795 million the same period last year.

Posted In: DVAX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist